Even minimal exposure to modern medicine can rapidly change the human microbiome. In a new study appearing in Cell Reports, ...
It has also improved cancer survival rates and helped people live longer, healthier lives, even with chronic conditions like ...
Even if you you’re not diabetic or obese, can Ozempic be right for you? Ever since the weekly injectable was approved in 2017 to treat diabetes in adults, researchers have been testing its superpowers ...
The “magic bullet” model that doctors are most comfortable with is ill-suited to some of the most disabling conditions they ...
Researchers said that while WHO programmes treating infectious diseases offer life-saving benefits, the treatments could be ...
Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges. In this episode, Kristi Martin, a longtime Washington, DC–based policy ...
The Orphan Drug Act has boosted treatments, but Kristi Martin, MPA, MA, urges modernizing incentives and pricing to sustain future innovation. Since its inception in 1983, the Orphan Drug Act has been ...
The drug development industry has grown into a troubling duality—one characterized by scientific progress and pervasive failure. Decades of technological advancements have enabled the precise ...